Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomized, double-blind comparison
Authors:
Bardur Sigurgeirsson a;
Boni E. Elewski b;
Phoebe A. Rich c;
Carol Opper d;
Bin Cai d;
Judit Nyirady d;
Rajesh Bakshi e
| Affiliations: | a Department of Dermatology, University of Iceland, Reykjavik, Iceland |
| b Department of Dermatology, Clinical Research, University of Alabama, Birmingham, Alabama, USA | |
| c Northwest Cutaneous Research Specialists, Portland, Oregon, USA | |
| d Novartis Pharmaceuticals Corp., East Hanover, New Jersey, USA | |
| e Novartis Pharma AG, Basel, Switzerland |
DOI:
10.1080/09546630500504713
Publication Frequency:
6 issues per year
Subject:
Dermatology;
Formats available:
HTML
(English)
:
PDF
(English)
Recommending 'Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomized, double-blind comparison'
This service is temporarily unavailable.
Please copy the URL in your address bar and email it direct to your colleague or librarian to recommend this resource.


Download Citation


